All News
All news
-
News Corning and Pfizer Announce Supply Agreement for Corning Valor® Glass Packaging
Pharmaceutical Technologies | Corning Incorporated | May 28, 2020Corning Incorporated (NYSE: GLW) and Pfizer Inc. (NYSE: PFE) today announced the execution of a long-term purchase and supply agreement for Corning Valor® Glass. -
News Corning Announces Pharmaceutical Glass Packaging Joint Venture in Bengbu, China
New manufacturing capacity will allow Corning to meet increased regional and global demand for high-quality glass tubing
Corning Incorporated (NYSE: GLW) today announced a joint venture (JV) agreement with Bengbu Innovation Venture Capital Co. Ltd. ... -
News U.S. Departments of Defense, Health & Human Services select Corning Valor® Glass packaging to accelerate delivery of COVID-19 vaccines
Pharmaceutical Technologies | Corning Incorporated | June 09, 2020Corning Incorporated (NYSE: GLW) today announced it will receive $204 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant... -
News Corning Announces FDA Approval of Valor® Glass for Packaging of Marketed Drug Product
Pharmaceutical Technologies | Corning Incorporated | October 25, 2019Corning Incorporated (NYSE: GLW) today announced that a leading pharmaceutical manufacturer has received FDA approval of Corning Valor® Glass for use as a primary package for a market... -
News AI targeting is helping us to better identify new nutra contacts
The Informa Markets team recently spoke with Tom Ongena, sales director Europe at Sirio Europe about his expectations for the first ever CPHI Festival of Pharma, what he is seeing in the industry and how the CDMO is approaching the virtual event. -
News Hydroxypropyl Betadex can improve the physicochemical properties of β - carotene
Hydroxypropyl Betadex can improve the physicochemical properties of β - carotene -
News Sterling Pharma Solutions launches £11 million Material Science Centre
Sterling has launched its multi-million-pound Material Science Centre at its headquarters in Dudley, Northumberland, UK. -
News Application of modified cyclodextrin in medicine
Betadex sulfobutyl ether sodium can play a good role in medicine -
News Betadex Sulfobutyl Ether Sodium promotes the development of new drug voriconazole eye drops
Betadex Sulfobutyl Ether Sodium promotes the development of new drug voriconazole eye drops -
News Characteristics of Carboxymethyl beta cyclodextrin sodium salt
Carboxymethyl beta cyclodextrin sodium salt -
News Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury® for COVID-19
Hovione announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol® -
News Hovione Announces the Appointment of Jean-Luc Herbeaux as Chief Operating Officer
Hovione announced today the appointment of Dr. Jean-Luc Herbeaux as Chief Operating Officer (COO), effective May 1st, 2020. -
News Successful MHRA regulatory inspection for Scottish CMO Symbiosis
Inspection conducted remotely using video-conferencing and an online private document sharing platform. -
News Novel customizable and flexible single-use assembly solution
Hugh Purity New England's solution can utilize other vendors' components and can be implemented directly into any process. -
News New thin film technology to revolutionize vaccine storage and distribution
Up to 500 doses of vaccine to be placed on a single wafer-thin and stored for extended periods of time. -
News ABDİ İBRAHİM AND ALVOTECH ENTER STRATEGIC PARTNERSHIP IN BIOTECHNOLOGY
Abdi İbrahim, Turkey’s leading pharmaceutical company having built the largest biotechnological manufacturing facility of the country, entered a strategic partnership with the Icelandic pharmaceutical company Alvotech to manufacture and launch biot... -
News ABDİ İBRAHİM ACQUIRES 28.5 PERCENT STAKE IN SWISS BIOTECH FIRM OM PHARMA, BECOMES THE FIRST TURKISH PHARMA COMPANY TO TAKE PART IN THE MANAGEMENT OF A EUROPEAN COUNTERPART
Abdi İbrahim, operating in the pharmaceuticals industry for the last 108 years, and the consecutive market leader in the last 18, took part in a Swiss joint venture that acquired OM Pharma, a 83-year pharma company based in Switzerland, one of the l... -
News Sterling Pharma Solutions launches £11 million Material Science Centre
The new centre will allow the company to improve efficiencies and reduce overall manufacturing time. -
News New preventative nasal spray treatment could protect from COVID-19 infection
Novel therapy developed by Australian biotech company, Ena Respiratory, shown to significantly reduce COVID-19 virus levels in the nose and throat. -
News CPHI Pharma Index highlights the importance of international partnering
Survey results reveal 84% of the industry is actively searching for new partners. -
News RESOMER® Precise
Evonik launches RESOMER® Precise platform of custom functional excipients to precisely control the release profile of parenteral drug products -
News Our PureActives® partnerships
With our innovative enzymatic platform, we've been changing the game for sustainable antibiotics and statins production, step by step. -
News Centrient achieves PNEC compliance for SSPs
Centrient achieves PNEC compliance for SSPs -
News Stevanato Group and Bexson Biomedical announce collaboration to develop a customized wearable ketamine delivery device
Patients suffering from chronic and acute pain disorders will benefit from a convenient, discreet, and easy-to-use device delivering a novel alternative to opioid-based pain management. -
News PharmaBlock Opens New Facility in Zhejiang, China
New chemistry and engineering technology center highlights the application of micropacked bed technology in continuous manufacturing -
News Strong partnership with DSV and United Airlines
To master logistic challenges even during the coronavirus crisis, va-Q-tec started a unique partnership with DSV and United Airlines. The cooperation ensures one of the most important transport routes for the regular transport of blood plasma despite l... -
News Coming soon: Our New Headquarters
Our New Headquarters located at Dr.-Robert-Pfleger-Strasse in Bamberg, Germany -
News Our Sustainability Report 2019
Sustainability matters a great deal to everyone at Centrient Pharmaceuticals, it is core to our mission and essential in shaping our authentic and purposeful culture. Our promise of Sustainability means that we not only ‘do what we say’, but also we ar... -
News Centrient Pharmaceuticals to boost statins manufacturing capacity
Doubling our API capacity to meet the growing demand -
News Marchesini Group Press Kit 2020
With a turnover of 441 million Euro in 2019 and 2,000 employees in Italy and abroad, Marchesini Group is a flagship of the Packaging Valley in Emilia Romagna and one of the top four worldwide manufacturers of automatic pharmaceutical and cosmetic packa... -
News New study further validates Bioiberica’s b-2Cool® native type II collagen as trusted source for holistic mobility solutions
New scientific research, published in Osteoarthritis and Cartilage, highlights the benefits of Bioiberica’s native (undenatured) type II collagen (b-2Cool®) in combination with other key ingredients for joint health: chondroitin sulphate, glucosamin... -
News Ingredients and Formulation - evolving opportunities and challenges
Ingredients are the lifeblood of the pharmaceutical and nutraceutical industries. They connect today’s cutting-edge medicine and consumer products makers with their origins in the chemicals sector of the late nineteenth century. While ingredients... -
News HK inno.N Corporation receives regulatory approval for first novel drug
Korean pharmaceutical firm HK inno.N Corp. said on Friday that its gastroesophageal reflux disease drug K-CAB has been approved by the Ministry of Food and Drug Safety, marking the first time for the company to launch an independently-developed novel d... -
News Almac Group Launches Biologics Testing Solutions
Athlone, Ireland - 15 September 2020 – Almac Sciences, a member of Almac Group, has announced the expansion of its existing suite of analytical solutions to include biologics testing. -
News Usin Near-Infrared spectroscopy and chemometric modeling to simultaneously determine ibuprofen and caffeine concentration in softgels
Appearing in the September 2020 edition of Tablets & Capsules, this article summarizes a method for rapid and accurate determination of API concentration in the fill of soft gelatin capsules while little or no sample preparation. Applying chemometric m... -
News Xellia Pharmaceuticals Opens New Commercial Office in Dubai
Xellia Pharmaceuticals Opens New Commercial Office in Dubai -
News Samyang Biopharm USA, Inc and CanCure LLC Announce Global Strategic Collaboration to Advance Novel Immuno-Oncology Therapeutic
Samyang Biopharm USA, Inc. (https://us.samyangbiopharm.com) a global biotech subsidiary of the Samyang Pharmaceuticals Corp. (https://samyangbiopharm.com/eng), announced today that the company has entered into a worldwide licensing agreement with CanCu... -
News Samyang Biopharm USA in-licenses Talix Therapeutics’ first-in-class compound
Samyang Biopharm USA has licensed in Belgium’s Talix Therapeutics’ first-in-class immuno-oncology compound for global rights. -
News US biosimilars five years on: Life on Mars?
Richard Saynor on LinkedIn -
News New collaboration between Novartis and Africa Medical Supplies Platform
New collaboration between Novartis and Africa Medical Supplies Platform to facilitate supply of COVID-19 related medicines. Novartis and the African Union (AU) through the Africa Medical Supplies Platform (AMSP) have announced a new collaboration ... -
News Sandoz launches generic antibiotic Daptomycin in US
Sandoz Inc. announced the US market introduction of Daptomycin for injection 500 mg, an AP-rated generic version of Cubicin® (daptomycin)*, for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by Gram-p... -
News Bushu Pharma investing $100M to grow its footprint and services over the next five years
Bushu Pharma – a leading CDMO in Japan – is investing USD100 million over the next five years to expand its footprint and services, helping the company better respond to the requirements of its customers. -
News Daewoong to export gastric acid blocker to Mexico
Daewoong Pharmaceutical has signed a deal worth $50 million to supply Mexico’s Moksha8 with gastric acid blocker Fexuprazan. Given the local authorities' approval plan, Moksha8 aims to launch Fexuprazan in the second half of 2022. -
News Daewoong Pharmaceutical Unveils Phase 3 Clinical Data of Fexuprazan, A Novel Potassium-competitive Acid Blocker
- Selected as a Poster of Distinction for presentation during Digestive Disease Week 2020
- Proved its efficacy with outstanding inhibition of gastric acid secretion and safety
- Proactively targeting the anti-acid secretion agent market valu... -
News Daewoong signs an export contract for Fexuprazan - Provided to EMS (Brazil) for 10 years after local approval in Brazil
On the August 14th, Daewoong signed an export contract with EMS in Brazil for the P-CAB-affiliated gastric secretion inhibitor Fexuprazan. The contract amount is $72.58 million. EMS will be responsible for the local approval of Fexuprazan in Brazil. -
News Daewoong Pharmaceutical signs overseas researchers’ clinical trial agreement for COVID-19 treatment
- Cooperative relations related to global joint research for COVID-19 drug Camostat (Daewoong Brand: Foistar)
- Daewoong’s Foistar enters phase 2 clinical trials... Scheduled to proceed to phase 3 clinical trials by end of year -
News Daewoong Pharm’s COVID-19 cure enters Phase 2 trial in Mexico
An investigator-initiated Phase 2 clinical trial of Daewoong Pharm’s COVID-19 drug candidate has been kicked off at several health centers in Mexico, including Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. The sponsor-invest... -
News World's first zero carbon emission autoinjector from Ypsomed
Ypsomed has developed the world’s first zero carbon emission prefilled autoinjector. The YpsoMate Zero is based on the proven YpsoMate autoinjector platform that offers convenient handling and patient safety. The new YpsoMate Zero uses alterna... -
News Introducing Bespak by Recipharm
In February 2020, Recipharm acquired Consort Medical plc, which included Bespak. The move was designed to strengthen Recipharm’s position as a leading inhalation company and one of the largest CDMOs in the world. -
News Remdesivir with Dexolve: fight against COVID-19
CycloLab, being involved in the fight, manufactures the critical excipient: sulfobutyl-ether-BCD (SBECD, Dexolve™) that enables Remdesivir to work. The unexpected and sudden outbreak along with the quick spread of the coronavirus-disease and rapid incr... -
News Alvotech and DKSH extend biosimilar partnership in Asia
The companies will commercialize six new biosimilar candidates addressing multiple therapeutic areas. -
News *Ultra Pure Sodium Hyaluronate* by Contipro
Please find company brochure attached that includes the ultra pure specification -
News Europital launches as a science-driven full-service CRO
Expanded CRO services to support biotechs and mid-sized pharma companies across trials in more than 40 countries. -
News Micreos initiates trial to evaluate world's first endolysin-drug as a therapy for atopic dermatitis
The targeted removal of one particular bacterial species from the skin microbiome, while preserving the beneficial ones, represents a new way to treat atopic dermatitis. -
News Tackling Issue of Pharmaceuticals in the Environment from Manufacturing Emissions
The second in a quarterly series of blog posts about responsible supply chain management from the PSCI Chair, Caroline O'Brien -
News Pope Updated Pope 3L, 4L, 5L Benchtop Nutsche Filter Dryers Now Available
The latest Pope Benchtop Nutsche Filter Dryers are now available for quick delivery. -
News T-knife and Catalent sign tech transfer and manufacturing agreement
Catalent to manufacture clinical batches of T-knife's platform process for TCR-based cell therapy at its site in Gosselies, Belgium, for European trials in 2021. -
News Metrics Contract Services begins $10M plant expansion
Clients set to benefit immediately through "higher yields" and "improved potent handling". -
News TESSA technology for robust and reproducible AAV manufacture at scale
Novel, plasmid-free manufacturing system reduces the cost of goods and improves AAV quality to enable development of safer gene therapies. -
News Formulation development : Ongoing orphan drugs development projects
Several ongoing development programs are dedicated to the manufacturing of orphan drugs intended for both US and European patients. Skyepharma team is proud to work on orphan drugs development projects. -
News R&D: Collaborative thesis on the mechanical resistance of tab-in-tab tablets - Progress to date.
R&D : Mechanical resistance of pharmaceutical press coated tablets (tab-in-tab): characterization and link with material and process parameters. -
News Pipeline - Vildagliptin + Metformin Product Profile
Vildagliptin & Metformin(50+850 mg), (50+1000 mg) Film Coated Tablets Reference Product: Eucreas® / Novartis
-
News Pipeline - Ertapenem Product Profile
Ertapenem 1gPowder for concentrate for solution for infusion
Reference Product: Invanz® / MSD -
News Pipeline - Isavuconazole Product Profile
Isavuconazole 200mg Powder for concentrate for solution for infusion
Reference Product: Cresemba® / Basilea Pharmaceutica (Pfizer) -
News Pipeline - Brivaracetam Product Profile
Brivaracetam 10mg/ml (5ml Vial) Solution for Injection/Infusion
Reference Product: Briviact® / UCB -
News Pipeline - Lacosamide Product Profile
Lacosamide 10mg/ml (20ml Vial)Solution for Infusion
Reference Product: Vimpat® / UCB -
News New Formulation & Sterile-Fill Finish Facility Online Open House on Oct 9
We’re kicking off the opening of our new, 32,000 sq. ft formulation and sterile fill-fill finish facility with a digital open house on October 9 from 1:00-2:00 pm EDT. We have a range of technical experts as our speakers including Maria Lacou... -
News Meet our Solid State specialists
This month we launch our multi-million-pound Material Science Centre, home to our Solid State specialists, as well as our new milling, micronisation and solid state chemistry services. Here, the team introduce themselves and share a little more ab... -
News EMBO CAPS® by Suheung LP+ Liquid Capsule
Supplied globally under the Embocaps® by Suheung brand, the Embocaps® LP+ is a hard capsule specifically designed to hold liquids and fine powders. The Embocaps® LP+ is available in multiple gelatin, vegetarian and relayed release formulations. -
News EMBO CAPS ® by Suheung opens new capsule factory
Suheung Co., Ltd. today announces the opening of their new EMBO CAPS® VG-ALPHA capsule facility located in the Long Thanh Industrial Zone (Dong Nai Province), Vietnam. Exclusively a vegetarian capsule facility, the new factory will supply capsules... -
News EMBO CAPS® by Suheung receives China DMF Number for Gelatin
EmboCaps® by Suheung announces today that the China DMF filing for Empty Hard Gelatin Capsule(F20190000400) successfully completed on December 30, 2019 -
News EMBO CAPS® by Suheung receives China DMF Number for HPMC
Suheung Co., Ltd. announces today that the China DMF filing for it’s EMBOCAPS ® Empty Hard HPMC Capsules has been successfully submitted and received its DMF filing acceptance notice / Pre-assigned DMF Number F20190000399. -
News Getinge launches the DPTE® Transfer Trolley - safe, smart and simple
Getinge launches the DPTE® Transfer Trolley – a smart, mobile transfer platform for use with all standard DPTE® Beta solutions for moving materials into and out of a confined zone without breaking containment or sterility. Its ergonomic, ... -
News Our CEO shares his thoughts on leading Nemera during the coronavirus pandemic in Pharma Post’s Special issue
None of us imagined we would be living through times like these. Every phase of this pandemic is unprecedented and we are inundated with guidelines to keep ourselves and our loved ones safe. We were not completely prepared for such a cris... -
News Nemera and Noble announce collaboration to support patients who self-administer medication
Nemera, world leader in design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generic industries, today announced a collaboration with Noble, the global leader in medical device training solution... -
News Nemera takes dermal treatments to millions of patients
Bioscience Today’s latest issue features Nemera’s article on how we strike the perfect balance of ensuring safety of our dermal drug delivery devices whilst fulfilling regulatory requirements and patient needs. -
News Nemera’s Insight Innovation Center celebrates a year of successful integration of expanded services
In August 2019, global drug delivery leader Nemera acquired top innovation services firm Insight Product Development. Today, Nemera’s Insight Innovation Center offers end-to-end development services from early to late-stage with design research, ... -
News “Smart, interactive and automated devices ergo ‘electronic’ are the future of drug delivery devices”
Drug Development Delivery’s latest issue features Nemera’s article titled: magazine includes an article from Nemera: ‘Mapping the regulatory strategy to better navigate electronic drug delivery device development for patient safety & security’ -
News Nemera awarded silver medal in the EcoVadis sustainability assessment
At Nemera we are committed to conducting business in an ethical and socially responsible way. Our people are passionate about making products that improve patient’s lives whilst being conscious about the impact we make on the world around us. We ... -
News Serialization and aggregation in the pharmaceutical industry
The serialization system allows the verification of a drug's compliance from the distribution to the delivery then to the patient. This article explains the serialization and aggregation implemented at Skyepharma. -
News Skyepharma Analytical Services : Specialized teams
Skyepharma is a full CDMO. We have an analytical service that covers all aspects from development to manufacturing. Packaging, raw materials and finished products are all controlled by this service. -
News Skyepharma overcomes Russian serialisation complexities
Skyepharma has extended its serialisation and aggregation service to ‘hard to reach’ countries like Russia and Brazil. We are now able to offer serialized and aggregated supplies to Russia. -
News Supply Chain Reliability at Skyepharma, David Lescuyer's Interview
This article describes the robustness of Skyepharma's supply chain. The delivery of our products has not been impacted during this COVID-19 pandemic. Discover how! -
News Thermo Fisher Scientific Opens New Bioprocessing Collaboration Center in St. Louis
Thermo Fisher Scientific Inc., the world leader in serving science, announced the opening of its new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri. -
News The pharmaceutical sector in the Gulf Cooperation Council and the impact of COVID-19
Countries in the GCC have been concentrating their efforts to develop and grow their healthcare and pharmaceutical sectors as an integral part of a ten-year vision to diversify the region’s economy and reduce its dependency on crude oil. While th... -
News Gilead Sciences agrees to buy Immunomedics in $21 billion deal
Acquisition will add Trodelvy, a first-in-class antibody-drug conjugate approved to treat breast cancer. -
News Stevanato Group to open US Technology Excellence Center in Boston
Due to begin operations in late September, the US TEC will bring value-added laboratory services to the heart of the biotech community. -
News Dexamethasone sodium phosphate in syrup
Discover our new Dexamethasone sodium phosphate in syrup 2mg/5ml -
News MACROGOL 3350 in stick pack and jar
Treatment of chronic, accasional or medication induced constipation.Pack: stick pack & jar
Fill: 5g - 10g- 200g -
News HYALURONIC ACID in Mesotherapy
Discover Hyaluronic Acid in Pre-Filled syringes & glass vials -
News Ensiemo, the new complete child-resistant packaging solution for cbd oils
SGD Pharma today announces the launch of its new full packaging solution dedicated to the cannabidiol (CBD) oil market. Combining the company’s extensive pharmaceutical packaging expertise with the need for compliant, safe packaging for CBD oils, ... -
News Maverick: an emergency auto-injector designed for total patient safety
The Maverick emergency auto-injector merges Duoject Medical System’s design and development expertise with Stevanato Group’s contract manufacturing capabilities. Six Human Factor studies conducted over 150 patients show how the current conf... -
News Medicine to beat the papiloma virus
Procare Health makes its way into the health sector with a gel to treat and prevent a disease that affects mainly women -
News Humanigen and Lonza collaborate to expand manufacturing of COVID-19 therapeutic candidate
Humanigen's proprietary monoclonal antibody may prevent and treat cytokine storm, which is believed to trigger the acute respiratory distress syndrome in severe cases of COVID-19. -
News Univercells Technologies introduces new upstream platform for virus manufacturing
The NevoLine Upstream platform has been designed to address the needs of gene therapy and vaccine innovators and CDMOs for robust and cost-effective upstream viral vectors manufacturing. -
News Mylan and development partner win significant EPO ruling related to Copaxone
Decision clears legal pathway to expand access for patients living with multiple sclerosis in markets across Europe. -
News Fertin Pharma Issued U.S. Patent for Oral Delivery Tablet Formed by the Compression of Unique Sugar Alcohol Combinations
U.S. Patent No. 10,632,076 B2 further strengthens Fertin Pharma’s intellectual property (IP) portfolio -
News Peter Halling to become new CEO of Fertin Pharma following resignation of Søren Birn
Peter Halling has been appointed CEO of Fertin Pharma as of August 2020. -
News Evotec and Bioaster partner to build technology and innovation hub in Lyon
Together, the companies will aim to put forward new research projects against infectious diseases and antimicrobial resistance, potentially creating new therapies and technologies. -
News Biogen invests $250 million to eliminate its use of fossil fuels
After achieving carbon neutrality in 2014, Biogen further bolsters its action against climate change with the goal to become fossil fuel free by 2040. -
News Annual Report preview for the CPHI Festival of Pharma
This preview from BioPlan Associates for the CPHI Festival of Pharma from 5-16 October, includes a summary of global trends and growth opportunities in biopharmaceutical product development and manufacturing and how the growth of domestic Mab pipelines... -
News Bushu Pharmaceuticals Quality Manufacturing of All Things Biotech
When western companies have established themselves in their regions, the Asian markets hold opportunities for their business expansion. In there, Japan is a one of prime targets for these expanding companies. However, launching into an unfamiliar marke... -
News Sai Life Sciences joins the ACS Green Chemistry Institute Pharmaceutical Roundtable
We have been committed to increasing the adoption of Green Chemistry principles in our process development. Joining the ACS-GCIPR will allow us to interact with large pharma and other CDMOs to further share and develop best practices in Green c... -
News Sai Life Sciences receives the 21st National Award for Excellence in Energy Management 2020
Following a string of wins over the past year, our Bidar manufacturing facility achieved another success to its credit - this time for excellence in energy management
-
News Stevanato Group Launches Robotic Human-like Inspection Unit with AI-based Machine Learning Capabilities
The Vision Robot Unit will provide biopharma companies with a fully automatized, highly accurate and flexible inspection system equipped with artificial intelligence for a variety of drug products, for increased operational efficiency. -
News Farmabios expands its portfolio with Cannabidiol API
Global API supplier Farmabios announced today the addition of an ultra-pure synthetic Cannabidiol (CBD) drug substance to its portfolio. With an EU Drug Master File and cGMP manufacturing capacities, Farmabios is now positioned to fulfill a secure and ... -
News Pharmapack 2021 opens entries for Patient-Centric Design Awards
The global pandemic continues to impact lots of industries and slow down business, but the pharma and packaging industries are striving to tackle new challenges to bring more faster and safer solutions to deliver medication to patients. The Pharmapack ... -
News The latest patient-centric packaging & drug delivery solutions revealed in Pharmapack 2020 Innovation Gallery
Pharmapack Europe, the leading conference & exhibition in pharma packaging & drug delivery business traded the successful 2020 edition at the beginning of February. The innovation gallery, as the key feature of this event, has gathered the most recent ... -
News What do Pharmapack Awards winners think about patient-centricity?
Pharmapack Awards winners and industry leaders will meet up in a live webinar at CPHI Festival of Pharma to discuss the evolution of next-generation products in pharma packaging, administration & drug delivery devices. -
News Sympfiny® acceptability study among young children with positive results
Scientists at the University of Birmingham, UK have evaluated Sympfiny® as device for orally dispensing multiparticulate drugs to children aged 4-12. -
News Sympfiny® showcase in OnDrugDelivery: The advantages of multiparticulate drug formulations in paediatric medicine
Multiparticulates, an emerging technology with many advantages over traditional dosage forms are particularly suited for use in paediatric medicine. The Sympfiny® system is specifically tailored to administering multiparticulate drug formulations,... -
News More than just wrapping a pill: improving patients’ lives through packaging
There is a great focus on medical packaging as a means of protecting the drug, but there is still a long way to go when talking about the real needs of patients, and what packaging can do for them. For the past six years, Giana Carli Lorenzini,Postdoct... -
News Evive Biotech Meets Primary and Secondary Endpoints in Global Phase III Clinical Trial for Their Novel Chemotherapy-induced Neutropenia Treatment
Evive Biotech, a global biologics company developing novel biological therapies, is delighted to announce that its pivotal Phase III study (NCT03252431) for F-627 (efbemalenograstim alpha) to treat chemotherapy-induced neutropenia (CIN) in breast cance... -
News VAV Lipids gets written confirmation from CDSCO for Ratnagiri facility
VAV Lipids announced that it has received written confirmation for their lecithin and phospholipids manufacturing facility at Ratnagiri, India pursuant to a successful inspection carried out by Indian CDSCO. The written confirmation is required fo... -
News Mylan to acquire Aspen's thrombosis business in Europe
The transaction will further complement and expand Mylan's complex injectables offering and presence in hospitals. -
News Nippon Express to provide global pharmaceutical supply networks
The company is already constructing a digital platform for the pharmaceutical industry that will utilize IoT devices and blockchain technology to link temperature control and other logistics information end-to-end. -
News Quotient Sciences Completes Million Dollar Pharmacy Expansion at Miami Clinic
Miami, FL/June 22, 2020 - Quotient Sciences, a global pharmaceutical development, clinical and commercial manufacturing organization, announced today the completion of a $1 million dollar pharmacy and laboratory expansion at their Miami, FL clinical ph... -
News Exelixis and Catalent collaborate to develop antibody-drug conjugates
The partnership will focus on developing multiple ADCs using Catalent’s proprietary SMARTag site-specific bioconjugation technology. -
News Key trends boosting the post-pandemic CRO market
Hybrid clinical trials leveraging safety-focused, direct-to-consumer logistical solutions are taking center stage, ensuring research continuity. -
News French cancer institute starts testing connected drug dispenser
THESS dispenser is equipped with an identity-vigilance system and warns patients when they need to take their treatment and verifies it has been delivered in accordance with the prescribed dose
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance